In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Aptose Biosciences Inc (NASDAQ: APTO) closed the day trading at $0.16 down -14.68% from the previous closing price of $0.19. In other words, the price has decreased by -$14.68 from its previous closing price. On the day, 8.76 million shares were traded.
Ratios:
For a better understanding of APTO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.05 and its Current Ratio is at 1.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on October 19, 2020, initiated with a Overweight rating and assigned the stock a target price of $10.
On September 22, 2020, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $12.
On February 20, 2020, Maxim Group started tracking the stock assigning a Buy rating and target price of $16.Maxim Group initiated its Buy rating on February 20, 2020, with a $16 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 25 ’24 when Rice William G. bought 100,000 shares for $0.20 per share. The transaction valued at 20,000 led to the insider holds 613,252 shares of the business.
Stock Price History:
Over the past 52 weeks, APTO has reached a high of $1.98, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is -20.21%, while the 200-Day Moving Average is calculated to be -66.60%.
Shares Statistics:
A total of 60.18M shares are outstanding, with a floating share count of 56.51M. Insiders hold about 6.10% of the company’s shares, while institutions hold 8.53% stake in the company.
